Closure of Skin in ChorioAmnionitis Research Pilot Study
CSCAR
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of the CSCAR pilot study is to improve the design of a full-scale trial by determining the patient recruitment rate and participation rate. The objective of the full-scale trial is to determine the optimal method of skin closure after Caesarean delivery in women with chorioamnionitis, which is an acute inflammation of the membranes and chorion of the placenta, seen typically after rupture of membranes with ascending polymicrobial bacterial infection. Women in labour with chorioamnionitis will be randomized at the time of Caesarean delivery to skin closure with either staples or sutures. The women will be followed at 6 weeks and 6 months post-partum in order to establish the occurrence of surgical site infection and wound disruption, as well as evaluation of the scar and other secondary questions. The investigators hypothesis is that closure of skin with sutures will have a rate of wound infection that is no higher than the rate of wound infection when closing skin with staples. The investigators also hypothesize that closure with sutures will have a decreased rate of wound disruption, increased patient satisfaction and decreased length of hospital stay compared to skin closure with staples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2013
CompletedFirst Posted
Study publicly available on registry
November 20, 2013
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedMay 12, 2017
May 1, 2017
5.8 years
October 31, 2013
May 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient recruitment rate
The patient recruitment rate will be calculated as the total number of women successfully recruited to the trial divided by the total duration of the trial.
1 year
Secondary Outcomes (6)
Follow-up rates
6 months post-operative
Wound infection
6 months post-operative
Wound disruption
6 months post-operative
Wound cosmesis
6 months post-operative
Patient satisfaction
6 months post-operative
- +1 more secondary outcomes
Study Arms (2)
Suture closure
EXPERIMENTALClosure of skin with a running subcuticular, absorbable monofilament suture.
Staples closure
ACTIVE COMPARATORClosure of skin with stainless-steel surgical staples.
Interventions
A running subcuticular suture is placed by taking horizontal bites through the papillary dermis on alternating sides of the wound. An absorbable suture is used and left in place until degraded and absorbed by the patient's tissues.
Surgical stapling devices re-appose skin edges with stainless steel or titanium staples. A second operator everts the wound skin edges while the operator applies staples along the incision. Staples can be removed on post-operative day 2 or 3, or delayed further according the surgeon preference based on patient characteristics.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of chorioamnionitis (Fever ≥ 38.0°C AND at least TWO of: Maternal tachycardia: Heart rate \> 100bpm, Fetal tachycardia: Baseline heart rate \> 160bpm, Uterine tenderness, Foul smelling / purulent vaginal discharge, White Blood Cell count \> 15,000 cells/mm3)
- Caesarean delivery with Pfannenstiel incision
- Pregnancies \>24 weeks
- Scheduled or non-elective procedures
- Primary or repeat Caesarean delivery
- No restrictions based on BMI
You may not qualify if:
- Non-Pfannenstiel incision
- Immune compromising disease
- History of keloid formation
- Chronic steroid use
- Allergy to staples
- Planned postpartum care at another facility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's and Women's Health Centre of British Columbia
Vancouver, British Columbia, V6H 3N1, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ellen M Giesbrecht, MD
Clinical Assistant Professor, Division of General Gynaecology & Obstetrics, Department of Obstetrics and Gynaecology, University of British Columbia; Site Head, Department of Obstetrics, BC Women's Hospital
- STUDY DIRECTOR
Jennifer A Hutcheon, PhD
Assistant Professor, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, University of British Columbia
- STUDY DIRECTOR
Julie E van Schalkwyk, MD
Clinical Assistant Professor, Division of General Gynaecology & Obstetrics, Department of Obstetrics and Gynaecology, University of British Columbia
- STUDY DIRECTOR
Michael WH Suen, MD
Resident, Department of Obstetrics and Gynaecology, University of British Columbia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 31, 2013
First Posted
November 20, 2013
Study Start
February 1, 2014
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
May 12, 2017
Record last verified: 2017-05